Defect Notification for Hiprex 1g Tablets Due to Braille Embossing Error
A Class 4 Medicines Defect Notification has been issued for Hiprex 1g tablets due to an error in Braille embossing on packaging.
Asset / Drug
Drug and asset intelligence for Defect with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.